Key Financial Data Of Reporting Company

Medrx Co.,Ltd. - Filing #7269497

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
As at
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
257,915,000 JPY
257,915,000 JPY
29,534,000 JPY
29,534,000 JPY
59,482,000 JPY
59,482,000 JPY
8,350,000 JPY
8,350,000 JPY
115,092,000 JPY
115,092,000 JPY
Ordinary profit (loss)
-780,959,000 JPY
-755,076,000 JPY
-930,634,000 JPY
-934,135,000 JPY
-1,112,190,000 JPY
-1,110,768,000 JPY
-1,063,489,000 JPY
-1,066,450,000 JPY
-1,149,863,000 JPY
-1,155,524,000 JPY
Profit (loss)
-825,684,000 JPY
-935,419,000 JPY
-1,109,727,000 JPY
-1,057,872,000 JPY
-1,118,443,000 JPY
Share capital
580,917,000 JPY
847,504,000 JPY
227,227,000 JPY
7,803,647,000 JPY
7,376,630,000 JPY
Total number of issued shares
47,495,100 xbrli:shares
38,365,100 xbrli:shares
28,224,100 xbrli:shares
24,595,100 xbrli:shares
19,435,100 xbrli:shares
Net assets
2,124,447,000 JPY
2,169,999,000 JPY
1,924,731,000 JPY
1,894,540,000 JPY
1,212,713,000 JPY
1,186,828,000 JPY
1,937,869,000 JPY
1,955,493,000 JPY
2,129,541,000 JPY
2,147,487,000 JPY
Total assets
2,157,236,000 JPY
2,275,600,000 JPY
2,052,252,000 JPY
2,021,759,000 JPY
1,398,266,000 JPY
1,373,139,000 JPY
2,091,201,000 JPY
2,108,589,000 JPY
2,279,241,000 JPY
2,297,368,000 JPY
Net assets per share
43.57
44.53
48.44
47.65
40.71
39.79
76.37
77.09
107.13
108.06
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-19.00
-18.56
-26.82
-26.90
-43.81
-43.75
-49.53
-49.62
-68.61
-68.85
Diluted earnings per share
Equity-to-asset ratio
0.959 xbrli:pure
0.929 xbrli:pure
0.906 xbrli:pure
0.904 xbrli:pure
0.822 xbrli:pure
0.818 xbrli:pure
0.898 xbrli:pure
0.899 xbrli:pure
0.914 xbrli:pure
0.914 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-803,403,000 JPY
-913,800,000 JPY
-1,073,292,000 JPY
-923,688,000 JPY
-985,354,000 JPY
Net cash provided by (used in) investing activities
-3,155,000 JPY
-759,000 JPY
-1,958,000 JPY
-2,542,000 JPY
-5,098,000 JPY
Net cash provided by (used in) financing activities
1,066,994,000 JPY
1,639,492,000 JPY
356,315,000 JPY
815,915,000 JPY
1,393,651,000 JPY
Cash and cash equivalents
1,977,638,000 JPY
1,720,720,000 JPY
994,025,000 JPY
1,703,644,000 JPY
1,812,360,000 JPY
Number of employees
21 xbrli:pure
22 xbrli:pure
22 xbrli:pure
22 xbrli:pure
21 xbrli:pure
22 xbrli:pure
21 xbrli:pure
22 xbrli:pure
23 xbrli:pure
23 xbrli:pure
24 xbrli:pure
Total shareholder return
0.270 xbrli:pure
0.497 xbrli:pure
0.313 xbrli:pure
0.421 xbrli:pure
0.694 xbrli:pure
Total return on share price index
1.825 xbrli:pure
1.515 xbrli:pure
1.181 xbrli:pure
1.211 xbrli:pure
1.074 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.